Used as a key intermediate in the synthesis of anxiolytic and anticonvulsant pharmaceuticals, particularly in the development of pyridotriazolopyrimidine-based central nervous system agents. Its structure enables selective binding to benzodiazepine receptors, making it valuable in creating drugs with reduced sedative side effects. Also employed in medicinal chemistry research to explore new GABA receptor modulators for treating anxiety, insomnia, and epilepsy.